Although cognitive dysfunction is a leading cause of disability and poor quality of life in patients with MS, it is infrequently tested in routine clinical evaluation. Development of a cognitive testing paradigm that captured MS-related cognitive dysfunction and could be obtained in a routine clinical setting may increase surveillance and recognition of cognitive dysfunction.
This is the next step to bringing value to my community by promoting cognitive health and using this device to conduct cognitive screenings.Amina Abubakar, PharmD, AAHIVP.
Validity, Reliability, and Psychometric Properties of a Computerized, Cognitive Assessment Test (Cognivue)
Comparison of the Cognivue Quantitative Assessment Tool and SLUMS to Classify the Risk of Cognitive Impairment
Validation, Reliability, and Psychometric Properties of Cognivue, A Quantitative Assessment of Cognitive Impairment
Novel Computer-Based Testing Shows Multi-Domain Cognitive Dysfunction in Patients With Multiple Sclerosis
Cognivue, Inc. has named Fred Ma, MD, PhD, as it’s Chief Medical Officer and Senior Vice President, effective immediately. His nearly four-decade career spans global medical device and pharmaceutical development and commercialization,…
Sign-up to schedule a Cognivue demo!Click Here